Correction: Change in number of shares and votes in Episurf Medical

Corrected information The correct number of Class B shares is 6,930,364,588, previously incorrectly stated as 6,929,891,231. The correct total number of votes is 6,931,784,659, previously incorrectly stated as 6,931,311,302. The total number of shares (6,930,837,945) and the number of Class A shares (473,357) were stated correctly and are unchanged. In full, the information shall read: As a result of, in accordance with previously announced information, the directed issue of 1,711,111,111 Class B shares resolved on…

Change in number of shares and votes in Episurf Medical

Through the above-mentioned changes, the total number of shares in Episurf amounts to 6,930,837,945, of which 473,357 are Class A shares and 6,929,891,231 are Class B shares, and the total number of votes in Episurf amounts to 6,931,311,302. For further information, please contact: Jens Andersson, CEO, Episurf Medical Tel: +46(0) 768 55 67 02 Email jens.andersson@episurf.com This information is information that Episurf Medical AB (publ) is obliged to make public pursuant to the Financial Instruments…

Episurf Medical has entered into a financing agreement for the KlaraBo acquisition and closing of the property portfolio takes place on 2 July 2026

Closing Closing of the entire property portfolio takes place on 2 July 2026. The financial closing takes effect as of 30 June 2026. For one of the properties, corresponding to an agreed property value of approximately SEK 233 mn, legal closing will take place no later than 18 months after the closing date. The reason for the deferred legal closing is that the property in question has a relatively large vacancy. Until legal closing, Episurf…

• Release

Conversion of convertibles in a nominal amount of SEK 37,519,480 to 833,766,222 Class B shares

Through the conversion, the number of Class B shares and votes in Episurf increases by 833,766,222, corresponding to a dilution effect of approximately 12.03 per cent of the shares and the votes respectively. Through the conversion, the share capital increases by SEK 8,337,662.22. For further details, please contact: Jens Andersson, CEO, Episurf Medical Tel: +46 (0) 768 55 67 02 Email: jens.andersson@episurf.com The information was submitted for publication, through the agency of the contact person…

• Release

Episurf Medical acquires Kuststaden Invest with a property portfolio at an agreed property value of SEK 647 mn

The acquisition in brief Episurf has entered into an agreement to acquire all shares in Kuststaden Invest AB, corp. reg. no. 559419-5231, including the company’s wholly owned property-owning subsidiaries. The sellers are the company’s current owners: NEEL Capital Partners AB (corp. reg. no. 559015-7706), Virbo Invest AB (corp. reg. no. 559015-7698), Polberga AB (corp. reg. no. 556338-7538), Magnus Johansson and Robert Pejic (jointly the “Sellers”). The property portfolio comprises twenty properties with a total lettable…

• Release

Episurf Medical acquires a mixed property portfolio of 30 properties in Södermanland and Östergötland with an agreed property value of SEK 920 mn from Livi Fastigheter AB

The acquisition in brief Episurf has entered into an agreement to acquire all shares in Grännäs Fastigheter Holding AB, reg. no. 559572-2470, and Goldcup 39848 AB, reg. no. 559585-9330, from Livi Fastigheter AB. The property portfolio comprises 30 properties and constitutes a mixed portfolio of residential properties and LSS housing. The lettable area amounts to approximately 51,000 sqm. The total agreed property value amounts to SEK 920 mn, with a possible deferred consideration of SEK…

The Board of Directors of Episurf has resolved on an issue of Class B shares, convertibles and warrants as part of the consideration for the acquisition of property assets

The Board of Directors of Episurf Medical AB (publ) ("Episurf" or the "Company") has today, by virtue of the authorisation granted by the Company's Annual General Meeting held on 25 May 2026, resolved on an issue of Class B shares and convertibles to Mofast AB (Publ) ("Mofast"), and warrants to Frusipe Intressenter Holding AB ("Frusipe Intressenter Holding"), as part of the consideration to be paid for the acquisition of property assets. The Frusipe Issue On…

Episurf Medical acquires a portfolio of four properties in Uppsala with an agreed property value of SEK 300 mn from Setune

The acquisition in brief The portfolio comprises four properties, primarily light warehouse and office, located in Boländerna in central Uppsala. The agreed property value amounts to SEK 285.5 mn. Annual rental income amounts to approximately SEK 21.6 mn and net operating income (NOI) to approximately SEK 17.5 mn, corresponding to a NOI yield of around 6 per cent. Closing is conditional on financing and is expected to occur no later than 1 November 2026. Financial…

• Release

Episurf Medical acquires properties in Borås

The acquisition in brief Two properties in Räveskalla, Borås (Räveskalla 1:435 and Räveskalla 1:506), with a total lettable area of 1,735 sqm. Agreed property value of SEK 12 mn after deduction of deferred tax. Fully let with a net operating income (NOI) of approximately SEK 1.0 mn per year, corresponding to a NOI yield of 8.4 per cent. Stable cash flows with a weighted average unexpired lease term (WAULT) of 6.5 years. Preliminary completion on…

• Release